BSE filing, NSE: SAIPARENT. Summary written from the filing by ALFA Finder's alert engine.
Sai Parenterals Ltd: key numbers
- Share price
- ₹521.95
- Market cap
- ₹2,306 Cr
- Revenue (annual)
- ₹381.0 Cr
- Net profit (annual)
- ₹14.26 Cr
- P/E (TTM)
- 111.0×Sector 45.9×
- Promoter holding
- 51.16%+0.00% QoQ
- FII holding
- 2.85%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sai Parenterals Ltd
All →Sai Parenterals Board Meeting Date
Sai Parenterals Ltd notified a Board Meeting on 1 Nov 2026 to approve unaudited Q2/H1 FY27 results. No financial figures or decisions are reported yet.
Sai Parenterals Acquisition Worth ₹15 Cr
Sai Parenterals Limited has acquired a 60% stake in Prathyak Laboratories Private Limited for ₹15 Crore. This acquisition provides an operational R&D facility in Hyderabad.
- Value
- ₹15.00 Cr
- product pipeline
- 150.0 SKUs
Sai Parenterals Other Announcement
Sai Parenterals Ltd submitted the Monitoring Agency Report for the quarter ended 30th June 2026 regarding the utilization of IPO proceeds, as per SEBI regulations.
Sai Parenterals Management Change
Sai Parenterals Limited appointed Mr. Ashwani Singh Bisht as Company Secretary and Mr. Arvind Gannimitta as COO. These appointments follow the resignation of Ms. Shivali Aggarwal.
Sai Parenterals Annual General Meeting
Sai Parenterals held its 25th Annual General Meeting on September 10, 2026. Shareholders approved financial statements, director appointments, and various company resolutions.
Sai Parenterals Bags ₹204 Cr Order
Sai Parenterals' subsidiary, Noumed Pharmaceuticals, renewed a 3-year OTC Medicines Supply Agreement with an Australian pharmacy chain, valued at approximately ₹204 Crore.
- Value
- ₹204.0 Cr
- Execution
- 3 years
Other board meeting outcome announcements
All →Teja Engineering Industries Board Meeting Outcome
Teja Engineering Industries informed NSE that its board appointed K. J. Tapiawala & Associates as internal auditor and N R Shah & Co as secretarial auditor for FY 2026-27. Both are routine appointments with no monetary value.
- Execution
- FY 2026-27
SC Agrotech Board Meeting Outcome
SC Agrotech's board approved shifting its corporate office to Sola, Ahmedabad, effective October 31, 2026. The registered office stays unchanged in Delhi.
Abril Paper Tech Board Meeting Outcome
Abril Paper Tech appointed K. J. Tapiawala & Associates as internal auditor for FY 2026-27. The appointment is a routine auditor change with no financial or operational impact.
- Execution
- Financial Year 2026-27
Bridge Securities Board Meeting Outcome
Bridge Securities' board approved moving its registered office within Ahmedabad, effective 31 October 2026. The routine administrative change has no financial impact.
VCU Data Management Board Meeting Outcome
VCU Data Management appointed M/s. Utkarsh Shah & Co. as Secretarial Auditors for five years from FY 2026-27, subject to AGM approval. No monetary amount is disclosed, so this is an auditor appointment intimation.
- Execution
- FY 2026-27 to 2030-31 (five years)
Hardcastle & Waud Manufacturing Company Board Meeting Outcome
The board revoked its earlier Mumbai office shift and approved moving the registered office to Mira Road, Thane. The change awaits shareholder and regulatory approval.